1. Home
  2. STRS vs SGHT Comparison

STRS vs SGHT Comparison

Compare STRS & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stratus Properties Inc.

STRS

Stratus Properties Inc.

HOLD

Current Price

$28.96

Market Cap

220.4M

Sector

Real Estate

ML Signal

HOLD

Logo Sight Sciences Inc.

SGHT

Sight Sciences Inc.

HOLD

Current Price

$5.20

Market Cap

235.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STRS
SGHT
Founded
1992
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Medical Specialities
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
220.4M
235.0M
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
STRS
SGHT
Price
$28.96
$5.20
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$9.08
AVG Volume (30 Days)
81.2K
129.1K
Earning Date
05-14-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
512.50
28.16
EPS
0.82
N/A
Revenue
$29,914,000.00
$77,363,000.00
Revenue This Year
N/A
$11.67
Revenue Next Year
N/A
$10.39
P/E Ratio
$35.54
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.35
$3.11
52 Week High
$32.93
$9.24

Technical Indicators

Market Signals
Indicator
STRS
SGHT
Relative Strength Index (RSI) 53.33 61.60
Support Level $28.51 $4.76
Resistance Level $29.99 $5.66
Average True Range (ATR) 0.96 0.30
MACD 0.13 0.04
Stochastic Oscillator 90.55 95.52

Price Performance

Historical Comparison
STRS
SGHT

About STRS Stratus Properties Inc.

Stratus Properties Inc is a diversified real estate company operating in the United States. It is engaged in the entitlement, development, management, leasing, and sale of multi-family and single-family residential and commercial real estate properties in the Austin, Texas area and other select markets in Texas. The company operates in two reportable segments: Real Estate Operations and Leasing Operations. Maximum revenue is generated from the Leasing Operations segment, which involves the leasing of commercial and residential properties developed by the company. The Real Estate Operations segment comprises properties under various stages of development: developed for sale, under development, and available for development.

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.

Share on Social Networks: